Original Source(s)
Related Content
FDA Clears Olastrocel Trial Expansion
Additional patients with ongoing opioid use are being enrolled as Creative Medical prepares for potential Phase 3 discussions with the FDA.
June 22, 2026
-
3 min
FDA Approves New Iohexol Vials
The approval includes additional 300 mg iodine/mL and 350 mg iodine/mL vial presentations.
July 17, 2026
-
2 min